Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GDXJ vs GSK✓SelectedUSD · GSKGDXJ vs GSK performance historyLatest closeAs of-6.02%11/18
Stock and ETF performance explorer

GDXJ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+25.3%
GSK return
+172.8%
Excess return
-147.4%
Maximum drawdown
-88.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.0%-1.3%-4.7%-5.5%
7D-13.8%-3.1%-10.7%-12.7%
30D-16.9%-0.9%-16.0%-16.6%
3M-22.0%-4.2%-17.8%-20.8%
6M-22.0%-1.6%-20.4%-22.1%
YTD-20.8%+2.6%-23.4%-22.6%
1Y-4.9%+6.2%-11.1%-8.6%
3Y+175.2%+55.0%+120.2%+115.4%
5Y+107.7%+42.8%+64.8%+66.3%
10Y+205.1%+102.1%+103.0%+103.3%
All+25.3%+172.8%-147.4%-33.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling